Tags

Type your tag names separated by a space and hit enter

Glycemic index, glycemic load, and thrombogenesis.
Semin Thromb Hemost. 2009 Feb; 35(1):111-8.ST

Abstract

Hyperglycemia and insulin resistance are independent risk factors for cardiovascular disease (CVD). Postprandial glycemic "spikes" adversely affect vascular structure and function via multiple mechanisms including oxidative stress, inflammation, low-density lipoprotein oxidation, protein glycation, and procoagulant activity. Glycemic responses can be reliably predicted by considering both the quantity and quality of carbohydrate. The glycemic index (GI), a measure of carbohydrate quality, has provided insights that knowledge of the sugar or starch content has not. In prospective observational studies, dietary GI and/or glycemic load (GL; the product of the amount of carbohydrate and GI) independently predict CVD, with relative risk ratios of 1.2 to 1.9 comparing highest and lowest quartiles. In randomized controlled trials in overweight subjects, diets based on low GI carbohydrates have decreased plasminogen activator inhibitor-1 activity and other CVD risk factors over and above that of conventional low-fat diets. Taken together, the findings suggest that clinicians may be able to improve CVD outcomes by recommending the judicious use of low GI/GL foods.

Authors+Show Affiliations

Institute of Obesity, Nutrition and Exercise, and Department of Medicine, University of Sydney and Royal Prince Alfred Hospital, Camperdown, NSW, Australia. j.brandmiller@mmb.usyd.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19308899

Citation

Brand-Miller, Jennie, et al. "Glycemic Index, Glycemic Load, and Thrombogenesis." Seminars in Thrombosis and Hemostasis, vol. 35, no. 1, 2009, pp. 111-8.
Brand-Miller J, Dickinson S, Barclay A, et al. Glycemic index, glycemic load, and thrombogenesis. Semin Thromb Hemost. 2009;35(1):111-8.
Brand-Miller, J., Dickinson, S., Barclay, A., & Allman-Farinelli, M. (2009). Glycemic index, glycemic load, and thrombogenesis. Seminars in Thrombosis and Hemostasis, 35(1), 111-8. https://doi.org/10.1055/s-0029-1214154
Brand-Miller J, et al. Glycemic Index, Glycemic Load, and Thrombogenesis. Semin Thromb Hemost. 2009;35(1):111-8. PubMed PMID: 19308899.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Glycemic index, glycemic load, and thrombogenesis. AU - Brand-Miller,Jennie, AU - Dickinson,Scott, AU - Barclay,Alan, AU - Allman-Farinelli,Margaret, Y1 - 2009/03/23/ PY - 2009/3/25/entrez PY - 2009/3/25/pubmed PY - 2009/5/21/medline SP - 111 EP - 8 JF - Seminars in thrombosis and hemostasis JO - Semin Thromb Hemost VL - 35 IS - 1 N2 - Hyperglycemia and insulin resistance are independent risk factors for cardiovascular disease (CVD). Postprandial glycemic "spikes" adversely affect vascular structure and function via multiple mechanisms including oxidative stress, inflammation, low-density lipoprotein oxidation, protein glycation, and procoagulant activity. Glycemic responses can be reliably predicted by considering both the quantity and quality of carbohydrate. The glycemic index (GI), a measure of carbohydrate quality, has provided insights that knowledge of the sugar or starch content has not. In prospective observational studies, dietary GI and/or glycemic load (GL; the product of the amount of carbohydrate and GI) independently predict CVD, with relative risk ratios of 1.2 to 1.9 comparing highest and lowest quartiles. In randomized controlled trials in overweight subjects, diets based on low GI carbohydrates have decreased plasminogen activator inhibitor-1 activity and other CVD risk factors over and above that of conventional low-fat diets. Taken together, the findings suggest that clinicians may be able to improve CVD outcomes by recommending the judicious use of low GI/GL foods. SN - 1098-9064 UR - https://www.unboundmedicine.com/medline/citation/19308899/Glycemic_index_glycemic_load_and_thrombogenesis_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-0029-1214154 DB - PRIME DP - Unbound Medicine ER -